Arcataur Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
4,630
-145
-3% -$33.8K 0.29% 38
2026
Q1
$1.17M Buy
4,775
+580
+14% +$135K 0.32% 36
2025
Q4
$868K Sell
4,195
-10
-0.2% -$1.98K 0.25% 43
2025
Q3
$780K Buy
4,205
+553
+15% +$94.7K 0.23% 45
2025
Q2
$558K Hold
3,652
0.17% 56
2025
Q1
$606K Sell
3,652
-250
-6% -$39.1K 0.21% 51
2024
Q4
$564K Hold
3,902
0.19% 56
2024
Q3
$632K Sell
3,902
-5
-0.1% -$797 0.21% 47
2024
Q2
$571K Sell
3,907
-85
-2% -$12.6K 0.2% 47
2024
Q1
$631K Hold
3,992
0.23% 42
2023
Q4
$626K Hold
3,992
0.24% 41
2023
Q3
$622K Hold
3,992
0.26% 39
2023
Q2
$661K Buy
+3,992
New +$644K 0.27% 37

Other funds holding JNJ

Arcataur Capital Management's JNJ Position: Q2 2026 in Review

Arcataur Capital Management reduced its Johnson & Johnson (JNJ) stake by 3% in Q2 2026, selling an estimated $33.8K and leaving 4,630 shares worth $1.18M. The position accounts for 0.29% of the portfolio, ranked #38.

Arcataur Capital Management first reported a position in JNJ in Q2 2023 and has held it in 13 quarters since. 3,826 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Arcataur Capital Management held 4,630 shares of Johnson & Johnson worth $1.18M as of Q2 2026.
  • Arcataur Capital Management sold 145 Johnson & Johnson shares in Q2 2026, an estimated $33.8K.
  • Johnson & Johnson made up 0.29% of Arcataur Capital Management's portfolio in Q2 2026, its #38 holding.
  • Arcataur Capital Management first reported a position in Johnson & Johnson in Q2 2023 and has held it in 13 quarters since.
  • 3,826 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Arcataur Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.